Page 105 - Read Online
P. 105

Page 99                  Chu et al. J Transl Genet Genom 2023;7:196-212  https://dx.doi.org/10.20517/jtgg.2023.22

               Laboratory handles and analyses approximately 350-500 samples per week, the majority of which are whole blood.
               During the first 24 months since the launch of the HKGP, 12,937 participants and their family members (6,680
               genomes) have been recruited and sequenced. The sequencing capacity of the Laboratory has been further
               enhanced to include the latest technologies, such as long-read sequencing and multi-omics in order to meet the
               target of the HKGP.

               Conclusion: HKGI Laboratory established a robust GS workflow for the HKGP. The clinical utility of GS will bring
               precision medicine into routine clinical practice.

               Keywords: Hong Kong Genome Project (HKGP), genome sequencing, genomic medicine, precision health,
               laboratory establishment



               INTRODUCTION
               Advances in DNA sequencing technologies have fueled the genome sequencing era and led to the initial
                                                                                                        [1]
               draft of the human genome sequence and, more recently, the telomere-to-telomere genome assembly .
               Disease-risk and treatment response studies  provided clinical interpretation of genomic variants and
                                                      [2,3]
                                                                               [4]
               paved the way for the development of genomic diagnostics and therapies . Substantial improvements in
               next-generation sequencing and bioinformatic tools have significantly shortened sequencing times, yielded
               higher sensitivity, specificity, and accuracy, better coverage, and reduced cost , democratising genome
                                                                                   [5,6]
               sequencing from the individual level to the population scale. This is reflected in the launch of national
               genome sequencing initiatives around the world, driving genomic medicine and improving healthcare
                                                                          [7]
               through the collection, storage, and application of genomic data . In 2015, China launched its first
               Precision  Medicine  Initiative , followed  by  neighboring  Asian  countries  such  as  Japan [9,10]   and
                                          [8]
                                                                                 [13]
               Thailand [11,12] . Other national genome projects have also emerged in France , the United Kingdom [14-17] ,
               Denmark , Australia [19-21] , Canada , the United States , Saudi Arabia , and Turkey [25,26] . The scale of
                                                               [23]
                                            [22]
                                                                             [24]
                       [18]
               these projects ranges from sequencing twenty-five thousand to one hundred million genomes using various
               genomic technologies, including DNA microarrays, RNA sequencing, targeted gene panel sequencing,
               exome sequencing (ES), and genome sequencing (GS) [7,27,28] , spanning four to fifteen years. As more genome
               projects are underway, we expect the catalog of human genomic variations and functional annotation to
               grow steadily [29,30] , marking a major step towards embedding genome sequencing into routine clinical care.
               Hong Kong has been a Special Administrative Region of the People's Republic of China since 1997. Hong
               Kong continues to have its own economic, legal, social, healthcare and welfare infrastructures despite being
               a recognised financial hub with modern city standards and a high standard of living. The latest population
               forecasts released by the Census and Statistics Department predict an increase in Hong Kong's population
                                                         [31]
               from 7.70 million in 2023 to 8.10 million in 2039 . Over 90% of the population of Hong Kong is of ethnic
               Chinese descent, according to the 2016 by-census , with other ethnic groups making up the remaining 8%.
                                                         [32]
               Hong Kong is viewed as a prime location to carry out studies on Southern Chinese populations' health due
               to this relatively homogeneous population. Shouldering about 90% of the inpatient needs of the entire
               community, the Hospital Authority provides a strong public healthcare safety net through 43 hospitals and
               institutions, 49 Specialist Out-patient Clinics (SOPCs), and 74 General Out-patient Clinics (GOPCs). With
               a well-established dual-track healthcare system, the remaining population also has easy access to privately
               funded healthcare.

               Hong Kong has embarked on her journey of developing genomic medicine. Following the release of the
               Policy Address in 2017, the Hong Kong Special Administrative Region Government established a Steering
                                            [33]
               Committee on Genomic Medicine . Upon reviewing the local landscape, the Committee put forward the
   100   101   102   103   104   105   106   107   108   109   110